Literature DB >> 15632405

Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003.

David Scheifele1, Scott Halperin, Barbara Law, Arlene King, Scott Halperin, Robert Morris, Charles A Janeway, Pierre Déry, Marc Lebel, Dorothy Moore, Nicole Le Saux, Elizabeth Ford-Jones, Ben Tan, Taj Jadavji, Wendy Vaudry, Wikke Walop, Joanne Embree, John Waters.   

Abstract

BACKGROUND: Although vaccination of infants against Haemophilus influenzae type b (Hib) invasive infections is effective and has been routinely available in Canada since 1992, cases of the disease continue to occur. We were interested in determining whether recent cases of Hib infection reflected progressive loss of protection with time since vaccination, increasing nonacceptance of vaccination or a deleterious effect of coadministration of recently introduced vaccines such as those for pneumococcal and meningococcal conjugates and hepatitis B. We report on the causes of Hib infections among vaccinated and unvaccinated children between 2001 and 2003 in Canada.
METHODS: Through our established network of 12 pediatric tertiary care hospitals we actively searched for cases in each centre by reviewing daily admissions and laboratory reports, visiting the wards and checking discharge diagnosis codes. Culture-confirmed cases were summarized by nurse monitors using a standardized reporting system.
RESULTS: We identified 29 cases during the 3 years: 16 in 2001, 10 in 2002 and 3 in 2003. Half of the 29 patients had meningitis. Hib infection was more common among children less than 6 months of age (11 cases) and in boys (20 cases). Two deaths occurred (7% case-fatality ratio). A total of 20 children had received no or incomplete primary vaccination because of parental refusal (7 cases), because they were too young to have completed the primary series (11 cases, including 1 in which parental refusal was also a factor) or because of delays in completing the primary series (2 cases); the vaccination history was uncertain in the remaining case. Infection despite primary vaccination occurred in 9 children: 2 previously healthy children and 7 who were immunocompromised or who had a predisposing condition. None of the cases identified in 2003 involved children who had received any of the newly introduced vaccines.
INTERPRETATION: Invasive Hib infections remain rare in Canada, with most cases occurring in children too young to have completed the primary series. Protection after vaccination appears to extend into later childhood and does not appear to be diminished by coadministration of newer infant vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632405      PMCID: PMC543945          DOI: 10.1503/cmaj.1031861

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

Review 1.  Haemophilus influenzae type B disease control using PENTACEL, Canada, 1998-1999.

Authors:  D Scheifele; S Halperin
Journal:  Can Commun Dis Rep       Date:  2000-06-01

2.  Historic low Haemophilus influenzae type B case tally--Canada 2000.

Authors:  D Scheifele; S Halperin; W Vaudry; T Jadavji; B Tan; B Law; N LeSaux; L Ford-Jones; M Lebel; D Moore; P Déry; R Morris; J Waters; J Embree; W Wallop
Journal:  Can Commun Dis Rep       Date:  2001-09-15

3.  Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis.

Authors:  J McVernon; N Andrews; M P E Slack; M E Ramsay
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

4.  Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.

Authors:  David W Scheifele; Scott A Halperin
Journal:  Semin Pediatr Infect Dis       Date:  2003-07

5.  Measuring up: results from the National Immunization Coverage Survey, 2002.

Authors:  L McWha; A MacArthur; T Badiani; H Schouten; T Tam; A King
Journal:  Can Commun Dis Rep       Date:  2004-03-01

6.  Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine.

Authors:  P Helena Mäkelä; Helena Käyhty; Tuija Leino; Kari Auranen; Heikki Peltola; Nina Ekström; Juhani Eskola
Journal:  Vaccine       Date:  2003-12-12       Impact factor: 3.641

7.  Haemophilus influenzae type B disease at 11 pediatric centres, 1996-1997.

Authors:  S Grewal; D Scheifele
Journal:  Can Commun Dis Rep       Date:  1998-07-01

8.  Recent trends in pediatric Haemophilus influenzae type B infections in Canada. Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control.

Authors:  D W Scheifele
Journal:  CMAJ       Date:  1996-04-01       Impact factor: 8.262

9.  Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage.

Authors:  R Singleton; L R Bulkow; O S Levine; J C Butler; T W Hennessy; A Parkinson
Journal:  J Pediatr       Date:  2000-09       Impact factor: 4.406

10.  Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease.

Authors:  J I Ward; H S Margolis; M K Lum; D W Fraser; T R Bender; P Anderson
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

View more
  9 in total

1.  Steroids in meningitis Part B: Clinical commentary.

Authors:  Wendy Vaudry
Journal:  Paediatr Child Health       Date:  2006-01       Impact factor: 2.253

2.  Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era.

Authors:  Raymond S W Tsang; Samira Mubareka; Michelle L Sill; John Wylie; Stuart Skinner; Dennis K S Law
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  When is it permissible to dismiss a family who refuses vaccines? Legal, ethical and public health perspectives.

Authors:  Beth Halperin; Ryan Melnychuk; Jocelyn Downie; Noni Macdonald
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

4.  Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda.

Authors:  Rosamund F Lewis; Annet Kisakye; Bradford D Gessner; Chaplain Duku; John Bosco Odipio; Robert Iriso; Denis Nansera; Fiona Braka; Issa Makumbi; Addy Kekitiinwa
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

5.  Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age.

Authors:  Ronald Gold; Luis Barreto; Santiago Ferro; John Thippawong; Roland Guasparini; William Meekison; Margaret Russell; Elaine Mills; Dana Harrison; Pierre Lavigne
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

6.  Delays in immunization have potentially serious health consequences.

Authors:  Fernando A Guerra
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Invasive Haemophilus influenzae Disease, Europe, 1996-2006.

Authors:  Shamez Ladhani; Mary P E Slack; Paul T Heath; Anne von Gottberg; Manosree Chandra; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

8.  Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005.

Authors:  Michael G Bruce; Shelley L Deeks; Tammy Zulz; Christine Navarro; Carolina Palacios; Cheryl Case; Colleen Hemsley; Tom Hennessy; Andre Corriveau; Bryce Larke; Isaac Sobel; Marguerite Lovgren; Carolynn Debyle; Raymond Tsang; Alan J Parkinson
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

9.  Invasive bacterial diseases in northern Canada.

Authors:  Naushaba Degani; Christine Navarro; Shelley L Deeks; Marguerite Lovgren
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.